Home Medicine First evaluation of Capillarys 2 Flex Piercing® (Sebia) as a new analyzer for HbA1c assay by capillary electrophoresis
Article
Licensed
Unlicensed Requires Authentication

First evaluation of Capillarys 2 Flex Piercing® (Sebia) as a new analyzer for HbA1c assay by capillary electrophoresis

  • Stéphane Jaisson EMAIL logo , Nathalie Leroy , Julie Meurice , Emmanuelle Guillard and Philippe Gillery
Published/Copyright: April 26, 2012

Abstract

Background: HbA1c is a key biomarker for the monitoring of glycemic balance in diabetic patients. It may be measured by various methods, including HPLC and immunoassays. Here we report the results of the first evaluation of Capillarys 2 Flex Piercing®, a new analyzer using capillary electrophoresis for the separation and the quantification of HbA1c.

Methods: We have evaluated the analytical performances of the method as well as the influence of the most frequent analytical interferences regarding HbA1c assays (i.e., labile HbA1c, carbamylated hemoglobin, high HbF and hemoglobin variants).

Results: Intra-assay and between-assays CVs were respectively lower than 1.98% and 2.68% on the pre-market version of the instrument, and lower than 1.62% and 1.45% on the commercial version. The linearity was excellent for HbA1c values ranging from 19 mmol/mol (3.9%) to 161 mmol/mol (16.9%) (r=0.999). The results were well correlated with those obtained by the HPLC method routinely used in the laboratory (Variant II® NU Kit – Bio-Rad): HbA1c[Capillarys 2]=0.9452×HbA1c[Variant II]+1.7279 (r=0.994, n=500). The use of titrated quality control samples indicated a good accuracy of the method. Neither the presence of HbF (until 15%), labile HbA1c or carbamylated hemoglobin, nor that of some typical hemoglobin variants, such as hemoglobin S, D, C and E, affected HbA1c measurement.

Conclusions: This evaluation showed that the analytical performances of Capillarys 2 Flex Piercing® analyzer for HbA1c assay fulfilled quality criteria requested for clinical use, and allowed to recommend its implementation in clinical chemistry laboratories for routine practice.


Corresponding author: Dr. Stéphane Jaisson, Laboratoire de Biologie et de Recherche, Pédiatriques, American Memorial Hospital, CHU de Reims, 47 rue Cognacq-Jay, 51092 Reims Cedex, France Phone: +33 3 26787562, Fax: +33 3 26783882

Received: 2012-1-11
Accepted: 2012-4-5
Published Online: 2012-04-26
Published in Print: 2012-10-01

©2012 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Editorials
  4. Cancer epigenomics: moving slowly, but at a steady pace from laboratory bench to clinical practice
  5. Laboratory networking and sample quality: a still relevant issue for patient safety
  6. Reviews
  7. DNA methylation biomarkers and their utility for solid cancer diagnostics
  8. DNA methylation biomarkers in biological fluids for early detection of respiratory tract cancer
  9. Global DNA hypomethylation in cancer: review of validated methods and clinical significance
  10. Genetics and Molecular Diagnostics
  11. δ0-Thalassemia in cis of βKnossos globin gene: first homozygous description in thalassemia intermedia Libyans and first combination with codon 39 (C→T) in thalassemia intermedia Tunisian patients
  12. Genetic-based reference values for angiotensin-converting enzyme (ACE) according to I/D polymorphism in a Spanish population sample
  13. General Clinical Chemistry and Laboratory Medicine
  14. Effects of sample transportation on commonly requested laboratory tests
  15. Long-term (in)stability of folate and vitamin B12 in human serum
  16. Information comparison of the effects of drugs on laboratory tests in drug labels and Young’s book
  17. First evaluation of Capillarys 2 Flex Piercing® (Sebia) as a new analyzer for HbA1c assay by capillary electrophoresis
  18. Antioxidant and oligonutrient status, distribution of amino acids, muscle damage, inflammation, and evaluation of renal function in elite rugby players
  19. Validation of the body fluid module on the new Sysmex XN-1000 for counting blood cells in cerebrospinal fluid and other body fluids
  20. Measuring Rivaroxaban in a clinical laboratory setting, using common coagulation assays, Xa inhibition and thrombin generation
  21. Cancer Diagnostics
  22. Increased concentrations of growth factors and activation of the EGFR system in breast cancer
  23. Infectious Diseases
  24. Incidence and significance of elevated lactate in the identification of critically ill patients
  25. Cardiovascular Diseases
  26. Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosis
  27. Diabetes
  28. Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes
  29. Letters to the Editor
  30. Establishing professional phlebotomist group for quality control of the preanalytic variables of clinical laboratory
  31. Application of quality specification based on biological variation in planning quality control strategy
  32. Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of infliximab and adalimumab
  33. Comparison of relationships between FT4 and log TSH in Access DXI 800 Unicel, Modular E170 and ADVIA Centaur XP Analyzer
  34. Assay-specific pitfalls of catecholamine HPLC assays
  35. Evaluation of automated nucleated red blood cells counting on Sysmex XE5000 and Siemens ADVIA 2120
  36. Evaluation of the immature myeloid information (IMI) by Sysmex XE 2100® hematology analyzer in the identification of blasts of myeloid lineage
  37. Congress Abstracts
  38. Congress of Laboratory Medicine and Clinical Chemistry / 4th Annual Meeting of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC)
  39. Abstracts of the 2012 Convocation of Experts on Laboratory Quality / Embracing the Need of Continued Vigilance to Assure Quality Outcomes in the Modern Laboratory
Downloaded on 6.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2012-0017/html
Scroll to top button